PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Bavarian Nordic to Acquire Emergent BioSolutions’ Vivotif, Vaxchora and an Under Developed Chikungunya Vaccine

Bavarian Nordic to Acquire Emergent BioSolutions’ Vivotif, Vaxchora and an Under Developed Chikungunya Vaccine

February 15, 2023

Insights+: The US FDA New Drug Approvals in January 2023

Insights+: The US FDA New Drug Approvals in January 2023

February 15, 2023

Coherus and Junshi Biosciences Report P-III Trial (JUPITER-02) Results of Toripalimab for Recurrent or Metastatic Nasopharyngeal Carcinoma

Coherus and Junshi Biosciences Report P-III Trial (JUPITER-02) Results of Toripalimab for Recurrent or Metastatic Nasopharyngeal C...

February 15, 2023

Ipsen, Université de Montréal and IRICoR Expands their Collaboration for Pre-Clinical Stage Program and two New Discovery-Stage Programs

Ipsen, Université de Montréal and IRICoR Expands their Collaboration for Pre-Clinical Stage Program and two New Discovery-Stage Pr...

February 15, 2023

Seres Therapeutics Reports P-III Trial (ECOSPOR IV) Results of SER-109 for the Prevention of Recurrent C. Difficile Infection

Seres Therapeutics Reports P-III Trial (ECOSPOR IV) Results of SER-109 for the Prevention of Recurrent C. Difficile Infection

February 15, 2023

Mirum Reports sNDA Submission to the US FDA for Livmarli (maralixibat) to Treat Cholestatic Pruritus in Progressive Familial Intrahepatic Cholestasis

Mirum Reports sNDA Submission to the US FDA for Livmarli (maralixibat) to Treat Cholestatic Pruritus in Progressive Familial Intra...

February 15, 2023

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
[email protected]
Newsletter

Our Information

Follow Us